Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP)

Homepage: regmed.ru

Alternate names: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’, Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation, Scientific Centre for Expert Evaluation of Medicinal Products, «Научный центр экспертизы средств медицинского применения» Министерства здравоохранения Российской Федерации (ФГБУ «НЦЭСМП» Минздрава России), Научный центр экспертизы средств медицинского применения

Parent institution: Ministry of Health of the Russian Federation

ROR: 05xze5t06

OpenAlex ID: I4405258012

Coronavirus disease COVID-2019

2020 · B. K. Romanov · Safety and Risk of Pharmacotherapy · 234

Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem

2018 · Vladlena I. Zozina, Serghei Covantev, et al. · Current Cardiology Reviews · 186

Interdisciplinary Clinical Practice Guidelines "management of Obesity and Its Comorbidities"

2021 · I. I. Dedov, M. V. Shestakova, et al. · Obesity and metabolism · 163

Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury

2016 · Igor Khalin, Renad Alyautdin, et al. · Drug Delivery · 121

The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019

2020 · Hye-Na Kang, Robin Thorpe, et al. · Biologicals · 68

Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness

2015 · Igor Khalin, Ganna Kocherga, et al. · International Journal of Nanomedicine · 61

Russian vaccines against especially dangerous bacterial pathogens

2014 · Valentina A Feodorova, Lidiya V Sayapina, et al. · Emerging Microbes & Infections · 60

Regulatory challenges with biosimilars: an update from 20 countries

2020 · Hye‐Na Kang, Robin Thorpe, et al. · Annals of the New York Academy of Sciences · 57

A mouse model of weight-drop closed head injury: emphasis on cognitive and neurological deficiency

2016 · Igor Khalin, NorLaili Azua Jamari, et al. · Neural Regeneration Research · 50

Review of medical image recognition technologies to detect melanomas using neural networks

2020 · Mila Efimenko, Alexander Ignatev, et al. · BMC Bioinformatics · 48

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance

2019 · M. V. Zhuravleva, B. K. Romanov, et al. · Safety and Risk of Pharmacotherapy · 48

Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

2022 · Veronika Voronova, Anastasia Vislobokova, et al. · Frontiers in Oncology · 47

Follistatin-Like Proteins: Structure, Functions and Biomedical Importance

2021 · Olga K. Parfenova, Vladimir G. Kukes, et al. · Biomedicines · 47

Animal-derived medicinal products in Russia: Current nomenclature and specific aspects of quality control

2019 · Ilya A. Prokopov, Elena L. Kovaleva, et al. · Journal of Ethnopharmacology · 45

Control of bronchial asthma in Russia: results of NIKA multi-center observational study

2011 · V. V. Arkhipov, E. V. Grigoryeva, et al. · PULMONOLOGIYA · 45

Flavonoids with Glutathione Antioxidant Synergy: Influence of Free Radicals Inflow

2020 · Igor Ilyasov, Vladimir Beloborodov, et al. · Antioxidants · 44

Treatment of COVID ‐19 patients with a SARS‐CoV ‐2‐specific siRNA ‐peptide dendrimer formulation

2023 · Musa Khaitov, Alexandra Nikonova, et al. · Allergy · 41

Phytochemical and Psychotropic Research of Motherwort (Leonurus cardiaca L.) Modified Dry Extracts

2021 · Oleh Koshovyi, Ain Raal, et al. · Plants · 40

Development of Paediatric Medicines: Key Risk Factors and Non-clinical Research Programmes

2023 · G. N. Engalycheva, R. D. Syubaev · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 36

Validation of an ICP-MS Method for the Determination of Mercury, Lead, Cadmium, and Arsenic in Medicinal Plants and Related Drug Preparations

2020 · V. M. Shchukin, E. S. Zhigilei, et al. · Pharmaceutical Chemistry Journal · 36

PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs

2022 · Nikolay Kuzmich, Elena Andresyuk, et al. · Molecules · 35

An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare

2020 · D. V. Gorenkov, L. M. Khantimirova, et al. · Biological Products Prevention Diagnosis Treatment · 34

Criteria for Assessment of Cognitive Impairment in Clinical Trials

2018 · A. P. Solovyova, D. V. Goryachev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 34

Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI).

2021 · Mikhail Khorolskiy, Galina Ramenskaya, et al. · PubMed Central · 33

Scope for the Application of Blockchain in the Public Healthcare of the Russian Federation

2018 · K.A. Koshechkin, G.S. Klimenko, et al. · Procedia Computer Science · 33

Works count: 1,691

Citation count: 12,330